US Stock MarketDetailed Quotes
RLMD Relmada Therapeutics
- 3.420
- -0.070-2.01%
Close Nov 4 16:00 ET
- 3.420
- 0.0000.00%
Post 16:02 ET
103.20MMarket Cap-1191P/E (TTM)
3.672High3.360Low114.16KVolume3.500Open3.490Pre Close392.78KTurnover0.42%Turnover RatioLossP/E (Static)30.17MShares7.22352wk High1.68P/B94.19MFloat Cap1.88052wk Low--Dividend TTM27.54MShs Float54.000Historical High--Div YieldTTM8.95%Amplitude1.810Historical Low3.440Avg Price1Lot Size
Relmada Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Nov 4, 2024
The average Relmada Therapeutics stock price target is 11.50 with a max estimate of 13.00 and a min estimate of 10.00
Review Relmada Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Nov 4, 2024
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data